Torrent Pharma accepts Amal Kelshikar’s resignation
In short
Torrent Pharmaceuticals has accepted Executive Director Amal Kelshikar’s resignation, effective at the close of business on 16 October 2026. Kelshikar said he was stepping down after reflection and felt it was the right time to move on.
This matters because the company is losing a senior executive. The report does not say who will replace him or what change, if any, will follow.
What the reporting says
Torrent Pharmaceuticals accepted Executive Director Amal Kelshikar’s resignation, effective at the close of business on 16 October 2026. Kelshikar said in his resignation letter that he was stepping down after reflection and believed it was the right time to transition. The reporting does not state who will replace him or whether the exit changes company operations.
Why it matters
Torrent Pharmaceuticals accepted Amal Kelshikar’s resignation as Executive Director, effective at the close of business on 16 October 2026. The available reporting says he described the move as a personal decision after reflection, but it does not give a business reason or succession plan. The impact is a leadership change at the company, with uncertainty remaining around replacement and any operational effect.